高等植物的3-羟基-3-甲基戊二酰辅酶A还原酶

介绍了植物3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)的结构和调控,并简略讨论了HMGR调控与植物类异戊二烯途径的关系.     

植物萜类合成酶3-羟基-3-甲基戊二酰辅酶A还原酶的生物信息学分析

采用生物信息学的方法和工具对已在GenBank上注册的橡胶、烟草、辣椒、穿心莲等植物的萜类合成酶3-羟基-3-甲基戊二酰辅酶A还原酶的核酸及氨基酸序列进行分析,并对其组成成分、信号肽、跨膜拓朴结构域、疏水性/亲水性、蛋白质二级及三级结构、分子系统进化关系等进行预测和推断。结果表明该类酶基因的全长包括5′、3′非翻译区和一个开放阅读框,无信号肽,是一个跨膜的亲水性蛋白,包括两个功能HMG-CoA结合motif及两个功能NADPH结合motif,α-螺旋和不规则盘绕是蛋白质二级结构最大量的结构元件,β-转角和延伸链散布于整个蛋白质中,蛋白质的功能域在空间布局上折叠成“V”形,“V”形的两臂由螺旋状的N结构域和S结构域构成,中间部分由L结构域构成。     

麦红吸浆虫3-羟基-3-甲基戊二酰辅酶A还原酶基因SmHMGR的克隆及在滞育与发育变态过程中的表达动态

【目的】3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)是保幼激素(JH)合成途径的限速酶。麦红吸浆虫Sitodiplosis mosellana是一种典型的专性幼虫滞育昆虫。本研究旨在探讨HMGR基因在麦红吸浆虫滞育和发育变态过程中的作用。【方法】通过RT-PCR和RACE技术克隆麦红吸浆虫滞育前幼虫HMGR基因全长cDNA序列;利用生物信息学软件分析HMGR基因核苷酸和其编码的蛋白氨基酸序列特性;采用qPCR技术测定其在麦红吸浆虫滞育不同时期3龄幼虫及不同发育阶段(1-2龄幼虫、预蛹、初蛹、中蛹和后蛹以及雌雄成虫)中的mRNA表达水平。【结果】克隆获得一条麦红吸浆虫HMGR基因全长cDNA序列,命名为SmHMGR(GenBank登录号: MG876766)。该基因全长2 548 bp,其中开放阅读框长2 328 bp,编码775个氨基酸,预测的蛋白分子量为84.16 kD,理论等电点为8.29。序列分析发现该基因编码的蛋白具有HMGR蛋白家族典型的HMG-CoA-reductase-classⅠ催化功能域及其他保守功能基序;序列比对和系统发育分析表明,SmHMGR与达氏按蚊Anopheles darling等长角亚目(Nematocera)昆虫HMGR的相似性最高、亲缘关系最近。SmHMGR在麦红吸浆虫滞育前的3龄早期幼虫中表达量显著升高,进入滞育后一直维持较高水平,并在滞育后静息阶段的当年12月至翌年1月达到最高。SmHMGR在蛹期表达量低于幼虫期,预蛹期表达量最低;在雌成虫中表达量显著高于在蛹和雄成虫中的表达量。【结论】SmHMGR的表达与麦红吸浆虫发育密切相关,可能在滞育诱导、维持及滞育后静息状态的维持及生殖中发挥作用,其表达量的降低可能参与了幼虫到蛹的变态。     

菊花等中药水煎剂对离体大鼠肝细胞微粒体羟甲基戊二酰辅酶A还原酶的作用机理

The isolated rat hepatic microsomal preparation was incubated with the aqueous extracts of Flos chryranthemi(菊花), Curcuma aromatica Salisb(郁金), Acan- thopanax senticosus (刺五加), Rhizoma ligustici wallichii (川芎), Radix polygoni multiflori (首乌) and Fructus crataegi pinnatifidae (山楂), respectively (37% 20 min). The activity of hydroxymethlglutaryl coenzyme A reductase was found to decrese about 30 % corresponding to the action of 50mmol/L NaF at similar condition. The mechanism of action of the Chinese drugs was the inhibition of cytosolic protein phosphatase and the activation of cytosolic hydroxymethylglutaryl CoA reductase kinase. Both the results of these two actions suppressed the activity of HMG-CoA reductase.     

植物肉桂酰辅酶A还原酶基因克隆研究进展

木质素单体合成的过程中涉及了许多酶的参与,而肉桂酰辅酶A还原酶(cinnamoyl-CoA reductase,CCR)是该过程中的一个关键酶。综述了CCR基因在植物体内的克隆、基因功能及在植物组织中的表达情况,并介绍了该基因在植物的抗病虫害和抗逆性研究、饲草和能源上的应用潜力,为进一步研究CCR基因生物学功能和利用奠定了基础。     

细纹豆芫菁3-羟甲基戊二酰辅酶A-还原酶基因全长cDNA克隆及生物信息学分析

3-羟甲基戊二酰辅酶A-还原酶（3-hydroxy-3-methylglutaryl coenzyme A reductase, HMGR）是甲羟戊酸途径的关键酶。获得芫菁体内HMGR基因信息是确定甲羟戊酸途径与斑蝥素合成相关性的基础。本研究利用RACE技术从细纹豆芫菁Epicauta mannerheimi (Maklin)体内克隆获得HMGR基因全长cDNA序列, 命名为EmHMGR（GenBank登录号为JQ690539）。该基因全长3 118 bp, 其中5′端非翻译区178 bp, 3′端非翻译区414 bp, 开放阅读框2 526 bp, 编码842个氨基酸。推测的蛋白质分子量为92.8 kDa, 理论等电点为6.0, 预测分子式为C₄₁₃₅H₆₆₀₄N1₀₉₈O₁₂₁₆S₅₀, 不稳定系数为43.37, 总亲水性系数为0.091, 为疏水性不稳定蛋白。序列分析发现该基因编码的蛋白与已报道的其他昆虫HMGR的氨基酸序列一致性达50%以上, 而且包含HMGR_Class I保守功能域、 固醇敏感多肽区及HMGR蛋白的其他保守功能位点。系统进化分析发现该基因与叶甲科昆虫HMGR基因的关系最近。本研究首次从芫菁科昆虫体内克隆获得甲羟戊酸途径的关键酶EmHMGR基因, 为后期芫菁体内斑蝥素生物合成途径的研究奠定了基础。     

京大戟hmgr基因家族3个保守区片段的克隆与分析

采用RT-PCR技术以及两条简并引物,以京大戟嫩叶总RNA反转录的cDNA为模板扩增3-羟基-3-甲基戊二酰辅酶A还原酶基因的保守区片断。序列分析表明,所克隆的cDNA保守区序列长度为458 bp,而且同时得到了三个不同的核苷酸序列,分别命名为hmgr1、hmgr2、hmgr3。与之前得到的京大戟hmgr保守区片段的核苷酸序列的同源性分别为98.03%、96.29%、78.38%,推断的相应氨基酸序列的同源性分别为98.68％、96.71%和85.53%。推断这可能是该基因家族中的三个新的成员。而且同源序列比对发现,由这三个核苷酸序列推断的氨基酸序列与其它植物都有较高的同源性。种系进化树分析表明hmgr3与hmgr1、hmgr2及以前报道的京大戟的hmgr之间有较大的差别。     

大戟甲羟戊酸途径关键酶基因hmgr的克隆与分析

通过比较6种植物8条甲羟戊酸途径关键酶3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)基因同源区域,设计简并引物,利用RT-PCR技术成功地从大戟(Euphorbia pekinensis)叶中扩增出458bp的基因片段。通过BlastP比较,所推断的大戟HMGR蛋白序列与杜仲Eucommia ulmoides(AAV54051)、穿心莲Andrographis paniculata(AAP14352)、胡黄连Picrorhiza kurrooa(ABC74565)、橡胶树Hevea brasiliensis(AAU08214)、海岛棉Gossypium barba-dense(ABC71314)、龙胆草Gentiana lutea(BAE92730)的一致性分别达到90%、86%、86%、92%、87%和88%。蛋白质保守区、特征区以及进化树分析,初步证实该基因为hmgr基因,这是首次报道从药用植物大戟中克隆到甲羟戊酸途径关键酶HMGR的基因片段。     

大戟甲羟戊酸途径关键酶基因hmgr的克隆与分析

通过比较6种植物8条甲羟戊酸途径关键酶3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)基因同源区域,设计简并引物,利用RT-PCR技术成功地从大戟(Euphorbia pekinensis)叶中扩增出458bp的基因片段。通过BlastP比较,所推断的大戟HMGR蛋白序列与杜仲Eucommia ulmoides(AAV54051)、穿心莲Andrographis paniculata(AAP14352)、胡黄连Picrorhiza kurrooa(ABC74565)、橡胶树Hevea brasiliensis(AAU08214)、海岛棉Gossypium barbadense(ABC71314)、龙胆草Gentiana lutea(BAE92730)的一致性分别达到90%、86%、86%、92%、87%和88%。蛋白质保守区、特征区以及进化树分析,初步证实该基因为hmgr基因,这是首次报道从药用植物大戟中克隆到甲羟戊酸途径关键酶HMGR的基因片段。     

南京椴HMGR基因的克隆和功能验证

3-羟基-3-甲基戊二酰辅酶A还原酶（3-hydroxy-3-methylglutaryl-CoA reductase,HMGR）是植物萜类代谢中甲羟戊酸途径的关键酶,本研究运用cDNA末端快速扩增（RACE）技术,首次从珍稀植物南京椴中克隆出HMGR的全长基因TmiHMGR,其长度为2 160 bp,包含一个1 758 bp的开放阅读框,其推导蛋白TmiHMGR编码585个氨基酸残基,相对分子量为62.9 kD,pI为6.11。将TmiHMGR与其他植物HMGR氨基酸序列构建进化树,结果显示TmiHMGR与苹果的HMGR聚为一枝。采用半定量RT-PCR分析TmiHMGR在根、茎和叶中的表达情况,结果表明该基因在茎中的表达量最高,根和叶中的表达量相对较弱。验证功能的颜色互补实验结果显示,TmiHMGR能够使代谢流明显朝类胡萝卜素合成的方向进行,说明TmiHMGR在萜类产物生物合成中是一个重要因子。     

Cloning and Characterization of a Root-specific Expressing Gene Encoding 3-hydroxy-3-methylglutaryl Coenzyme a Reductase from Ginkgo biloba

3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGR, EC: 1.1.1.34) catalyzes the first committed step in mevalonic acid (MVA) pathway for biosynthesis of isoprenoids. The full-length cDNA encoding HMGR was isolated from Ginkgo biloba for the first time (designated as GbHMGR, GenBank accession number AY741133), which contained a 1713 bp ORF encoding 571 amino acids. The GbHMGR genomic DNA sequence was also obtained, revealing GbHMGR had four exons and three introns. The deduced GbHMGR protein showed high identity to other plant HMGRs and contained two trans-membrane domains and a catalytic domain. The three dimensional model of GbHMGR represented a typical spatial structure of HMGRs. The Southern blot and RT-PCR assay results indicated that GbHMGR belonged to a small gene family, and expressed in a tissue-specific manner with a low level expression being only found in root. The potential significance of GbHMGR gene was also discussed.     

Interference with the determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and its properties by a microsomal enzymic activity.

Rat liver microsomes and microsomal extracts contain an enzymic activity which competes with 3-hydroxy-3-methylglutaryl coenzyme A reductase for 3-hydroxy-3-methylglutaryl coenzyme A. The presence of this activity in enzyme preparations causes errors in the determination of reductase activity and its properties. This contaminant can be removed by gel filtration using Bio-Gel A 1.5m, by washing the microsomes, or by incubating the microsomal extract at 37 °C. The K_m's of the reductase (free of this competing enzymic activity) for d-3-hydroxy-3-methylglutaryl coenzyme A and NADPH are 1.3 and 26 μm, respectively.     

Effect of an unnatural phospholipid base analog,N-isopropylethanolamine,on 3-hydroxy-3-methylglutaryl coenzyme a reductase in cultured glial and neuronal cells

Cultured C-6 glial and neuroblastoma cells were utilized to study the effect of the unnatural amino alcohol, N-isopropylethanolamine, on the microsomal enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase. Growth of both cell types in the presence of the compound was accompanied in 24 hr by a decrease in reductase activity to 25–35% of activity in control cells. The effect was accompanied by a comparable decrease in the rate of cholesterol synthesis. However, no comparable change occurred in cell growth, fatty acid synthetase activity, or in total protein synthesis from [³H]leucine. The data suggest that the polar head groups of microsomal membrane phospholipids play an important role in the regulation of reductase activity.     

Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cells

Summary 1. The relationships among the mevalonic acid (MVA) forming enzyme, 3-hydroxy-3-methylglutaryl coenzyme A (CoA) reductase, cell growth and differentiation, and the cytotoxic effects of the reductase inhibitor lovastatin were studied in PC-12 cells, exposed to growth factors.2. When added individually, nerve growth factor (NGF), basic fibroblast growth factor, and epidermal growth factor induce an increase in HMG-CoA reductase activity in cells grown in serum-containing medium. In the presence of serum, the effect of NGF on HMG-CoA reductase is persistent.3. Short-term serum starvation and long-term NGF treatment, in combination, have an additive effect, resulting in a high reductase activity.4. Unlike serum and MVA, which downregulate levels of HMG-CoA reductase by accelerating its degradation, NGF upregulates reductase by slowing the rate of its degradation. This mechanism, however, appears to operate only in the presence of serum, as after prolonged growth with NGF in serum-free medium, cells have a low reductase activity.5. PC-12 cells grown in the absence of NGF are highly sensitive to lovastatin (25 µM) and more than 70% of the cells die after 48 hr. NGF confers lovastatin resistance on cells grown in the presence or in the absence of serum (only 30–40% cell death after 48 hr with lovastatin).6. NGF-induced resistance on lovastatin develops with time and is apparent only in the well-differentiated PC-12 cells whether or not the cells express a high reductase activity.7. Thus, levels of HMG-CoA reductase activity and lovastatin resistance in PC-12 cells are not directly correlated, though clearly inversed lovastatin cytotoxicity and elevated reductase activities are expressed during the period of cell proliferation.8. These data suggest that fully differentiated neuronal cells may not be affected by prolonged high doses of lovastatin.     

Human hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: evidence for the regulation of enzymic activity by a bicyclic phosphorylation cascade

Microsomal human liver HMG-CoA reductase has been shown to exist in active (dephosphorylated) and inactive (phosphorylated) forms. Microsomal HMG-CoA reductase was inactivated in vitro by ATP-Mg in a time dependent manner; this inactivation was mediated by reductase kinase. Incubation of inactivated enzyme with phosphatase resulted in a time dependent reactivation (dephosphorylation). Polyacrylamide gel electrophoresis of purified HMG-CoA reductase incubated with reductase kinase and radiolabeled ATP revealed that the 32P radioactivity and HMG-CoA reductase enzymic activity were localized in a single electrophoretic position. Partial dephosphorylation of the phosphorylated enzyme was associated with loss of 32P and increase in HMG-CoA reductase activity. Human reductase kinase also exists in active and inactive forms. The active (phosphorylated) form of reductase kinase can be inactivated by incubation with phosphatase. Phosphorylation of inactive reductase kinase with ATP-Mg and a second kinase, reductase kinase kinase, was associated with a parallel increase in the enzymic activity of reductase kinase and the ability to inactivate HMG-CoA reductase. The combined results present initial evidence for the presence of human HMG-CoA reductase and reductase kinase in active and inactive forms, and the in vitro modulation of its enzymic activity by a bicyclic phosphorylation cascade. This bicyclic cascade system may provide a mechanism for short-term regulation of the pathway for cholesterol biosynthesis in man.     

The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons

Epidemiological studies demonstrate a relationship between statin [3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor] usage and reduced risk of developing Alzheimer's disease. To determine whether statins affect neuronal development, we treated cultured rat hippocampal neurons with pravastatin. After 4-48 h of treatment, pravastatin significantly increased the number of neurites produced by each cell and caused a corresponding increase in levels of the membrane phospholipid phosphatidylcholine. Pravastatin treatment also significantly increased neurite length and branching but did not affect cellular cholesterol levels. Co-incubation with mevalonate, but not cholesterol, abolished the stimulatory effect of pravastatin on neurite outgrowth. Treatment of neurons with isoprenoids also abolished the effect of pravastatin on neurite growth, suggesting that pravastatin may stimulate neuritogenesis by preventing isoprenylation of signaling molecules such as the Rho family of small GTPases. A specific inhibitor of geranylgeranylation, but not farnesylation, mimicked the stimulatory effect of pravastatin on neuritogenesis. Pravastatin treatment significantly decreased levels of membrane-associated RhoA. These data suggest that pravastatin treatment increases neurite outgrowth and may do so via inhibiting the activity of geranylgeranylated proteins such as RhoA.